These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 3689020)
1. Lymphocyte transformation in cutaneous leishmaniasis patients. Sells PG; Goldring OL Ann Trop Med Parasitol; 1987 Apr; 81(2):105-16. PubMed ID: 3689020 [TBL] [Abstract][Full Text] [Related]
2. Cross reactivity between Trypanosoma cruzi and Leishmania antigens in the lymphocyte blastogenesis assay. Carvalho EM; Reed SG; Johnson WD Trans R Soc Trop Med Hyg; 1987; 81(1):82-4. PubMed ID: 3127960 [TBL] [Abstract][Full Text] [Related]
3. Cutaneous leishmaniasis in Ethiopia: I. Lymphocyte transformation and antibody titre. Schurr E; Kidane K; Yemaneberhan T; Wunderlich F Trop Med Parasitol; 1986 Dec; 37(4):403-8. PubMed ID: 3563321 [TBL] [Abstract][Full Text] [Related]
4. Demonstration of an indomethacin-sensitive mechanism regulating immune reactivity in American cutaneous leishmaniasis patients. Castes M; Trujillo D; Scott D; Rondon AJ Clin Exp Immunol; 1987 Aug; 69(2):280-90. PubMed ID: 3652533 [TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection. Campbell SA; Alawa J; Doro B; Henriquez FL; Roberts CW; Nok A; Alawa CB; Alsaadi M; Mullen AB; Carter KC Vaccine; 2012 Feb; 30(7):1357-63. PubMed ID: 22210224 [TBL] [Abstract][Full Text] [Related]
6. [Determination of the specificity of seric IgA produced in response to antigens of Leishmania (Leishmania) mexicana in murine leishmaniasis]. Pérez-Aguilar MC; Hernández O; Maizo de Segnini Z; Rojas CH; Díaz S; Alarcón M; Goncalves L Invest Clin; 2011 Sep; 52(3):216-29. PubMed ID: 21950193 [TBL] [Abstract][Full Text] [Related]
10. Selection of a skin test antigen for American visceral leishmaniasis. Reed SG; Badaró R; Masur H; Carvalho EM; Lorenco R; Lisboa A; Teixeira R; Johnson WD; Jones TC Am J Trop Med Hyg; 1986 Jan; 35(1):79-85. PubMed ID: 3946739 [TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs. Porrozzi R; Santos da Costa MV; Teva A; Falqueto A; Ferreira AL; dos Santos CD; Fernandes AP; Gazzinelli RT; Campos-Neto A; Grimaldi G Clin Vaccine Immunol; 2007 May; 14(5):544-8. PubMed ID: 17314229 [TBL] [Abstract][Full Text] [Related]
12. Anti-leishmanial polyclonal antibodies to assess the performance characteristics of leishmanial antigen detection ELISA. Azazy AA; Al-Shibani LA; Mohammad Ael-S J Egypt Soc Parasitol; 2008 Dec; 38(3):1027-36. PubMed ID: 19209783 [TBL] [Abstract][Full Text] [Related]
14. Immune serum from both susceptible and resistant strains of mice increases phagocytosis of Leishmania mexicana amazonensis by macrophages. Reis MG; Roters SB; Barral-Netto M Acta Trop; 1987 Sep; 44(3):339-42. PubMed ID: 2892370 [TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum. Bras-Gonçalves R; Petitdidier E; Pagniez J; Veyrier R; Cibrelus P; Cavaleyra M; Maquaire S; Moreaux J; Lemesre JL Infect Genet Evol; 2014 Jun; 24():1-14. PubMed ID: 24614507 [TBL] [Abstract][Full Text] [Related]
16. Heterologous protection by Leishmania donovani for Leishmania major infections in the vervet monkey model of the disease. Gicheru MM; Olobo JO; Anjili CO Exp Parasitol; 1997 Feb; 85(2):109-16. PubMed ID: 9030661 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the micro enzyme-linked immunosorbent assay (ELISA) for antibodies in American visceral leishmaniasis: antigen selection for detection of infection-specific responses. Badaró R; Reed SG; Barral A; Orge G; Jones TC Am J Trop Med Hyg; 1986 Jan; 35(1):72-8. PubMed ID: 3080918 [TBL] [Abstract][Full Text] [Related]
18. Variable dependency on BAFF in IgG antibody production during Leishmania infection. Azuma N; Omachi S; Hanazawa W; Morimoto A; Sanjoba C; Matsumoto Y; Fujii W; Goto Y Parasitol Int; 2020 Feb; 74():101997. PubMed ID: 31626986 [TBL] [Abstract][Full Text] [Related]
19. Application of an improved method for the recombinant k 39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh. Kurkjian KM; Vaz LE; Haque R; Cetre-Sossah C; Akhter S; Roy S; Steurer F; Amann J; Ali M; Chowdhury R; Wagatsuma Y; Williamson J; Crawford S; Breiman RF; Maguire JH; Bern C; Secor WE Clin Diagn Lab Immunol; 2005 Dec; 12(12):1410-5. PubMed ID: 16339064 [TBL] [Abstract][Full Text] [Related]
20. Leishmania braziliensis guyanensis dermal leishmaniasis: cell-mediated immunity related to clinical features. Barbier D; Goyot P; Dedet JP Trans R Soc Trop Med Hyg; 1985; 79(1):47-50. PubMed ID: 3887683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]